Skip to main content

Advertisement

Table 4 Comparison of demographics and comorbidities between with and without diagnostic ureteroscopy in patients with upper tract urothelial carcinoma

From: The diagnostic ureteroscopy before radical nephroureterectomy in upper urinary tract urothelial carcinoma is not associated with higher intravesical recurrence

  URS+ URS- P-value
Mean±SD/ (N,%) Mean±SD/ (N,%)
  3,079 (53.9) 2,634 (46.1)  
Gender
 Male (N, %) 1,346 (43.72%) 1,126 (42.75%) 0.462
 Female (N, %) 1,733 (56.28%) 1,508 (57.25%)  
Age (Mean±SD) 67.79 (±10.68) 67.63 (±11.15) 0.599
Age (N,%)
 <65 years 1,092 (35.47%) 952 (36.14%) 0.491
 65-74 years 1,150 (37.35%) 944 (35.84%)  
 >74 years 837 (27.18%) 738 (28.02%)  
CCI score (N,%)
 0 272 (8.83%) 341 (12.95%) <0.001*
 1 217 (7.05%) 245 (9.30%)  
2 2,590 (84.12%) 2,048 (77.75%)  
Comorbidity
 Hypertension
  No 1,443 (46.87%) 1,300 (49.35%) 0.061
  Yes 1,636 (53.13%) 1,334 (50.65%)  
 Hyperlipidemia
  No 2,371 (77.01%) 2,138 (81.17%) <0.001*
  Yes 708 (22.99%) 496 (18.83%)  
 Diabetes
  No 2,345 (76.16%) 2,054 (77.98%) 0.103
  Yes 734 (23.84%) 580 (22.02%)  
 ESRD
  No 2,490 (80.87%) 2,072 (78.66%) 0.038*
  Yes 589 (19.13%) 562 (21.34%)  
  1. CCI Charlson Comorbidity Index, ESRD End-stage renal disease
  2. *p<0.05